Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:

CEI Impact

Treatment Options for Opioid Use Disorder: Does X:BOT Mark the Spot?

Access Activity

Overview / Abstract:

Treatment of opioid use disorder is challenging as many prescribing barriers exist that limit a patient’s access to treatment. This application-based continuing pharmacy education course will provide a 'journal club format’ discussion for pharmacists, student pharmacists, and residents to compare extended-release naltrexone to the more restricted agent buprenorphine-naloxone in the X:BOT trial. Join us to discuss the importance of increasing access to this much needed treatment as well as the role of pharmacists in educating prescribers about all treatment options for opioid-use disorder.


Aug 08, 2021


Pharmacy CPE


Online, Webinar / Webcast / Video



Credits / Hours




Presenters / Authors / Faculty

Kelly Hoenig,
PharmD, BCPS
Director of Clinical Pharmacy
Cedar Rapids Medical Education Foundation

Keywords / Search Terms

CEI CEI ce, law, federal, pharmacy, update, legislative, regulatory, pbm, provider status, act

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.